Cardiovascular health

ISSFAL publishes guidelines on analysis of omega-3 blood status in clinical research

09-Dec-2019 By Stephen Daniells

The International Society for the Study of Fatty Acids and Lipids (ISSFAL) has released new guidelines to encourage best practice in clinical trial design and study interpretation.

From the editor's desk

Looking for the best the weight management category has to offer

06-Dec-2019 By Hank Schultz

The growing obesity epidemic has flummoxed public health officials. Unfortunately, the dietary supplement industry has a checkered history in helping to find solutions.

Safety review backs natural astaxanthin, but holds off on synthetic forms

06-Dec-2019 By Hank Schultz

A recent review of astaxanthin found evidence to support the safety of dosages of 12 mg up to 24 mg a day. But that applies to only to natural astaxanthin, not to the synthetic forms, the authors said.

Consumer Reports calls attention to the importance of vitamin K

06-Dec-2019 By Stephen Daniells

Many people – and older men in particular – are not getting enough vitamin K, says a new article by Consumer Reports that draws attention to the benefits of the vitamin.

Kaneka launches novel innovation award program: Free product and then a clinical trial grant

02-Dec-2019 By Stephen Daniells

Probiotics player Kaneka has launched an innovation awards program, giving current and prospective clients the opportunity to receive free units of its Floradapt products.

Omega-3 studies support heart health benefits, dismiss prostate concerns

25-Nov-2019 By Stephen Daniells

Higher blood levels of omega-3 are not associated with an increased risk of prostate cancer, according to new data published last week at the 2019 American Heart Association Scientific Sessions in Philadelphia.

NIU’s Global Round-up: Antioxidants & telomere length in Brazilian kids, key immunity-boosting probiotic metabolite identified, and more

25-Nov-2019 By Stephen Daniells

What's happened this week around the Nutra-Verse? Stay on top of things with our weekly round-up of key news from across the globe.

DSM bridging personalized nutrition gaps with acquisition of digital platform

19-Nov-2019 By Hank Schultz

Dutch ingredients giant Royal DSM has acquired AVA, a Boston-based company that offers a digital personalized nutrition platform.

What the industry needs to know about polypharmacology

18-Nov-2019 By Danielle Masterson

Historically, our healthcare system has been focused on sick care. One expert wants to put the spotlight on polypharmacology, a lesser-known technique used in well care.

Immediate action needed to protect medicinal plants from climate change, paper argues

18-Nov-2019 By Hank Schultz

Urgent action is needed to assess and mitigate the risks climate change poses to medicinal plants, according to a paper published on Friday.

Omega-3 may improve brain health in people with heart disease: Study

15-Nov-2019 By Danielle Masterson

The study found taking omega-3 fatty acid supplements was associated with better brain function in people with coronary artery disease.

Vascepa’s label expansion could boost supplement realm

15-Nov-2019 By Hank Schultz

An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s.

Editor's Spotlight

More data fueling explosion of personalized nutrition

13-Nov-2019 By Hank Schultz

Additional data will continue to fuel the growth of personalized nutrition, participants in a panel discussion said.

Prebiotics group concurs with $5.5 billion figure on global market

11-Nov-2019 By Hank Schultz

Growing consumer awareness along with demand in animal nutrition is driving the overall growth of prebiotics, which a trade group says will account for $5.5 billion in sales in 2019. Better messaging can help maintain that momentum, the group says.

GOED: Omega-3 clinical trials database will boost claims, help identify research gaps

11-Nov-2019 By Stephen Daniells

A database that includes 4,000-plus clinical trials on EPA and DHA omega-3s will help companies with claims substantiation, and provide ready access to significant scientific data to counter negative consumer media articles, says GOED’s executive director.